Male and female 8-10-week non-sibling DO mice (n = 280) were exposed to a single 0 mg (n=70), 5 mg (n=90), or 10 mg (n=120) dose of transoral crystalline silica in PBS. After 12 weeks, lung pathology was scored and BALF was measured for cytokines and other silicosis biomarkers. Mean±standard deviation (SD) are reported in one column while the affected/total numbers (n) and percent (%) in parenthesis are in the second column for each dose. The percent positive cutoff was defined as the mean plus two SD of the control 0 mg group for each phenotype. Abbreviations: BALF, bronchial alveolar lavage fluid; LDH, lactate dehydrogenase. Mice and exposure to silica as in Table S1 . After 12 weeks exposure kidney pathology was scored and serum immunoglobulins and autoantibodies were quantified. Mean±standard deviation (SD) are reported in one column while the affected/total numbers (n) and percent (%) in parenthesis are in the second column for each dose. The percent positive cutoff was defined as the mean plus two SD of the control 0 mg group for each phenotype except ANA which was considered positive for ANA>0. ENA5 was run only on ANA + mice. RNP, Sm, SSA, SSB, and dsDNA were run on a subset of ENA5 + mice. Abbreviations: ANA, anti-nuclear antibody; ENA5, designed for the detection of anti-Sm, -RNP, -SS-A (60kDa and 52kDa), -SS-B and -Scl-70 IgG; Proteinuria; urine protein using Chemstrip assay. Mice and exposure to silica as in Table S1 . After 12 weeks exposure, lung pathology was scored and BALF quantified for cytokines and other silicosis biomarkers. Spearman correlation coefficients (rs) were calculated and interpreted as very weak (0- Mice and silica exposure as in Table S1 . Lung pathology scores, BALF analysis, and serological measurements as in Tables S1 and S2 . Spearman correlation coefficients (rs) were calculated and interpreted as very weak (0-0.19), weak (0.20-0.39), moderate (0.40-0.59), strong (0.60-0.79), or very strong (0.8-1.0). The 95% confidence interval (95% CI), sample size, and P-values are shown.
